Psychemedics 
Article published in The Washington Post April 26, 2017 By Ashley Halsey III For the first time, statistics show that drivers killed in crashes are more likely to be on drugs than drunk. Forty-three percent of drivers tested in fatal crashes in 2015 had used a legal or illegal drug, eclipsing the 37 percent who tested above … Read more
ACTON, Mass., Aug. 2, 2017,/PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced second-quarter financial results for the period ended June 30, 2017. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 14, 2017, to be paid on August 24, 2017. This will be the … Read more
Acton, Massachusetts, January 31, 2017 — Psychemedics Corporation (NASDAQ:PMD) today announced that recent volatility in its stock price on January 31, 2017 appears to have been caused by a news report of a court ruling in Brazil involving Psychemedics Brasil. Psychemedics Brasil is an independent distributor of Psychemedics Corporation’s hair testing services in Brazil, and … Read more
TheTrucker.com Wednesday, January 18, 2017 Six major carriers file formal request to allow hair analysis with the Federal Motor Carrier Safety Administration. The request is for an exemption from current federal regulations in order to allow hair analysis in lieu of urine testing for pre-employment controlled substances testing of commercial driver’s license holders. The Six … Read more
Award-Winning Customer Support Team is now a “Certified Center of Excellence” ACTON, Mass., Sept. 13, 2016 /PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD), the world’s leading and largest hair analysis drug testing company, announced that it has been certified as a Center of Excellence by BenchmarkPortal. The Center of Excellence recognition is one of the most prestigious … Read more
DECLARES 80th CONSECUTIVE DIVIDEND — 20 YEARS OF QUARTERLY DIVIDENDS ACTON, Mass., July 26, 2016,/PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced second-quarter financial results for the period ended June 30, 2016. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 5, 2016, to be … Read more
Myth: Confirmed levels of metabolite concentrations in urine are directly proportionate to usage (i.e. the more drug you take, the more you have in your system) Fact: There are several studies discussing how drug metabolite disposition varies among individuals and dosage levels. In the previously referenced manuscript by Dr. Marilyn Huestis and Dr. Edward Cone, … Read more
Myth: Hair testing is ‘new science’ and is not ready for prime-time. Fact: Hair testing was brought to the commercial marketplace by Psychemedics in 1987 after ten years of extensive research and development. With millions of hair tests already conducted for employers, child protection agencies, and police forces all over the world, the scientific validity has … Read more